Happy, confused or downright depressed? Companies say how they feel about EU pharmacovigilance rules
This article was originally published in SRA
Executive Summary
Drug manufacturers are still struggling to understand what is required of them under the EU's sweeping new pharmacovigilance legislation, a snap poll by the UK Medicines and Healthcare products Regulatory Agency has suggested.